December 2019 Editor's Choice
Listen to Gynecologic Oncology
English - December 24, 2019 17:00 - 16 minutesScience Health & Fitness medicine health care science and technology health national health service medical disease cancer politics diabetes Homepage Download Google Podcasts Overcast Castro Pocket Casts RSS feed
Editor's Choice Paper: A phase II randomized, double-blind trial of a polyvalent Vaccine-KLH conjugate (NSC 748933 IND# 14384) + OPT-821 versus OPT-821 in patients with epithelial ovarian, fallopian tube, or peritoneal cancer who are in second or third complete remission: An NRG Oncology/GOG study
Editorial Paper: Sunset, or dawn of a new age for ovarian cancer vaccine therapy?
Hosted by: Dr. Barbara Goff, Deputy Editor
Featuring: Dr. O'Cearbhaill, Dr. Jazaeri, Dr. Goff